And the ability of tumor-associated DCs (TADCs) and MoDCs to take up and process immune complexes (IC) containing tumor antigens bound to antitumor antibody, ultimately inducing anti-tumor immunity in vivo, was augmented by simultaneous inhibition of PTPN6 and phosphatases regulating AKT activation (206). This evidence concerns the gene AKT1 and neoplasm.